A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration. (Q51109245)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 November 2007
edit
Language Label Description Also known as
English
A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
scientific article published on 5 November 2007

    Statements

    A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit